intramuscular glp-1 agonists GLP-1 Receptor Agonists: Mascots & Mnemonics

Does Regence Cover Semaglutide (Wegovy)

More people with type 1 diabetes are using GLP-1 drugs, study finds, despite limited evidence on safety or effectiveness | CNN

A new Medicare program could expand access to GLP-1 weight-loss medications starting in 2026. For Med Spas offering physician-supervised GLP -1 programs, this could lead to more patients asking about eligibility and

Glucagon-like peptide-1 receptor agonists: an emerging hope against nephrolithiasis risk reduction via body weight reduction | International Urology and Nephrology | Springer Nature Link

Glucagon-like peptide 1 receptor agonists and cancer risk: the good, the bad and the unknown | Nature Reviews Clinical Oncology

Early trials of GLP-1 based drugs have shown promising results in patients with heart failure with preserved ejection fraction. A new study in JAMA uses real-world evidence that complements these trials.